Drugs / IFN-Kinoid
last change Dec 2019 re-read 3 minutes ago

IFN-Kinoid

Developed for
dermatomyositis
Investigated by
Neovacs

Trials 1

2018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT02980198 May 2017 → Dec 2019 dermatomyositis Neovacs Withdrawn No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as IFN-Kinoid ClinicalTrials.gov intervention name — accepted as the source's own label NCT02980198 ↗
Route Intramuscular “IM administration” NCT02980198 ↗